<DOC>
	<DOCNO>NCT02952079</DOCNO>
	<brief_summary>The goal study compare treatment - BlephEx MiBoFlo - good option patient suffer dry eye secondary Meibomian Gland dysfunction .</brief_summary>
	<brief_title>Comparison BlephEx MiBoflo Treatment Options Blepharitis</brief_title>
	<detailed_description>The investigator previously study effect BlephEx instrument ( debridement lid debris ) relieving sign symptom blepharitis ( Connor CG et al , ARVO 2014 ) . This previous study demonstrate positive result BlephEx treatment . Warming eyelid ( e.g. , use warm wash cloth ) still remain viable treatment option disease . However , patient often non-compliant warm compress therapy due requirement perform least twice per day . The MiBoflo delivers uniform consistent amount heat eyelid . It suggest two treatment 30 day adequate relieve sign symptom Meibomian gland dysfunction . This equipment currently use optometric practice country . There clinical study compare BlephEx MiBoflo treatment option blepharitis . Hence , current study provide new useful information treatment option may better treat blepharitis Meibomian gland dysfunction . Part study also investigate combination BlephEx MiBoflo treatments beneficial patient . The data generate directly benefit clinical practice impact several million patient suffer Blepharitis / Meibomian gland dysfunction .</detailed_description>
	<mesh_term>Blepharitis</mesh_term>
	<criteria>Must dry eye secondary Meibomian gland dysfunction ( posterior blepharitis ) Must active ocular surface infection . Must currently use steroid immunosuppression eye drop .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>